BRADYKININ B2 RECEPTOR GENE POLYMORPHISM ANALYSIS IN HYPERTENSIVE PATIENTS AT DR SAIFUL ANWAR HOSPITAL MALANG

Authors

  • Johan Aloysius
  • Nashi Widodo

Abstract

Hypertension is a major health problem in the world. When blood volume is low, juxtaglomerular cells in the kidneys secrete renin and prorenin activates the blood circulation. Plasma renin converts angiotensinogen released by the liver into angiotensin I, which is then converted to angiotensin II by the enzyme angiotensin converting enzyme (ACE) located in the pulmonary vascular endothelium. Angiotensin II causes blood vessels to constrict, resulting in increased blood pressure. ACEi inhibit the formation of angiotensin I into angiotensin II, and activate Bradykinin (BK), which causes blood vessels to dilate, thereby reducing blood pressure. However, administration of ACEi periodically cause the accumulation of BK in pulmonary vessels that cause inflammation (cough) in some people who suspected mediated by Bradykinin B2 receptor (BK2R) gene. Total of the subjects in this study is 52 subjects, DNA extracted from white blood cells (leukocytes) as much as 200 mL from whole blood by using the QIAamp kit (Qiagen). Gene BK2R in humans amplified by the method of Polymerase Chain Reaction (PCR) method using the following primers F (5-GCAGAGCTCAGCTGGAGGCG-3), and R (5-CCTCCTCGGAGCCCAGAAG-3) and identified by the method of Single Strand Conformation Polymorphism (SSCP). Results of this study shows three different genotypes there are CC, CT, and TT. Subjects with the CC genotype were most susceptible to cough, and subjects with CT genotype were least susceptible.

 

Keywords : ACE inhibitors, B2 Receptor, Cough, SSCP

References

Kuoppala A, Lindstedt KA, Saarinen J, Kovanen PT, Kokkonen JO (2000) Inactivation of Bradykinin by Angiotensin-Converting Enzyme and by Carboxypeptidase N in human plasma. Am J Physiol Heart Circ Physiol 278: 1069-1074.

Sweitzer, Nancy K. 2003. What Is an Angiotensin Converting Enzyme Inhibitor? Journal of The American Heart Association. Circulation.

Norman MK and Burton DR (2000) Major Side Effects of ACE Inhibitors. Diabetes Care 14: 34-39.

Yousef, G.M. and Diamandis E.P. 2007. The New Human Tissue Kallikrein Gene Family:Structure, Function and Association to Disease. Endocri Rev 22: 184-204.

Zintzaras E, Raman G, Kitsios G, Lau J. 2008. Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 2008; 168: 1077-1089.

Mukae, S., Aoki, S., Itoh, S., Iwata, T., Ueda, H., and Katagiri, T. 2000. Angiotensin-Converting Enzyme Inhibitor Related Cough Receptor Gene Polymorphism Is Associated With Bradykinin B2 Receptor. Hypertension. 36:127-131.

Qiagen. 2012. DNA Mini and Blood Mini Handbook. Page:26-28. http://www.qiagen.com/ Diakses tanggal 15 November 2013.

Woo, S.W., Bang, S., Chung, M.W., Jin, S.K., Kim, Y.S., Lee, S.H. 2009. Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans. Blackwell Publishing Ltd, Journal of Clinical Pharmacy and Therapeutics, 34, 561–567.

Benbouza, H., Jacquemin, J.M., Baudoin, J.P., Mergeai, G. 2006. Optimization of a reliable, fast, cheap and sensitive silver staining method to detect SSR markers in polyacrylamide gels. Biotechnol. Agron. Soc. Environ.2006 10 (2), 77 – 81.

Zhu, X. Niu, N., Liu, Y., Du, Te., Chen, D., Wang, X., Gu, H.G. 2006. Improvement of the sensitivity and resolution of PCR-SSCP analysis with optimized primer concentrations in PCR products. Journal of Genetics, Vol. 85, No. 3.

Downloads

Published

2014-07-10

How to Cite

Aloysius, J., & Widodo, N. (2014). BRADYKININ B2 RECEPTOR GENE POLYMORPHISM ANALYSIS IN HYPERTENSIVE PATIENTS AT DR SAIFUL ANWAR HOSPITAL MALANG. Biotropika: Journal of Tropical Biology, 2(1), 51–54. Retrieved from https://biotropika.ub.ac.id/index.php/biotropika/article/view/223

Issue

Vol. 2 No. 1 (2014)

Section

Articles

License

Copyright and Attribution:

Articles in Biotropika: Journal of Tropical Biology are under Creative Commons Attribution-NonCommercial (CC-BY-NC) copyright. The work has not been published before (except in the form of an abstract or part of a published lecture or thesis) and it is not under consideration for publication elsewhere. When the manuscript is accepted for publication in this journal, the authors agree to the automatic transfer of the copyright to the publisher.

Journal of Biotropika: Journal of Tropical Biology is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).

Permissions:

Authors wishing to include figures, tables, or text passages that have already been published elsewhere and by other authors are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from one of the authors.

Ethical matters:

Experiments with animals or involving human patients must have had prior approval from the appropriate ethics committee. A statement to this effect should be provided within the text at the appropriate place. Experiments involving plants or microorganisms taken from countries other than the author's own must have had the correct authorization for this exportation.